Custom Synthesis Pricing: What Drives Your Quote

Custom synthesis pricing is the part of the outsourcing relationship that buyers understand least and suppliers explain worst. A quote arrives as a single number with a delivery date attached, no visible arithmetic, and no indication of which part of the request drove it. So buyers do the only thing available to them: they collect three quotes and take the middle one. That works about as well as picking a route by coin flip.

The number is not arbitrary. Behind it sits a costing exercise a process chemist ran on your specific structure, and that exercise turns on maybe eight variables. Some of them are fixed by your molecule and nothing can be done about them. Several of them are set by your request rather than your chemistry, and those are the ones worth understanding, because you can change them.

This post is the pricing chapter of our CRO buyer’s guide. It goes through each driver, shows the arithmetic where the arithmetic is the point, and closes with a table of specific levers a buyer can pull. If you are still at the stage of assembling the request itself, start with what to include in a custom synthesis RFQ and come back here.

Route Length: Why Step Nine Costs More Than Step Two

The single largest driver of a custom synthesis quote is the number of linear steps in the route, and the cost per step is not constant — later steps are dramatically more expensive than early ones.

The reason is compounding. Every step carries a yield below 100 percent, so material lost at step eight was already carried through seven prior steps of labor, reagents, solvent and analysis. When you lose a gram at step two, you lose a gram of cheap material. When you lose a gram at step nine, you lose a gram that has absorbed eight steps of accumulated cost.

Linear Versus Convergent Routes

A linear route builds the molecule one step at a time from a single chain: A to B to C to D. A convergent route builds two or three fragments separately and joins them near the end. For the same total number of chemical operations, a convergent route is almost always cheaper, because losses in each branch compound only within that branch rather than across the whole sequence.

This is why a supplier’s route proposal matters more than their hourly rate. A chemist who finds a convergent disconnection where you assumed a linear one can take 30 percent off the quote before a single flask is set up. It is also why “just follow the literature route” is sometimes the expensive instruction: published routes are optimized for a first synthesis in a graduate lab, not for kilo-scale cost.

What Counts as a Step for Pricing

Not every operation prices the same. For costing purposes, treat these as distinct:

1. Bond-forming steps — full cost: reagents, vessel time, workup, purification, in-process control
2. Protection and deprotection — full step cost with zero structural progress, which is why route designs that avoid protecting groups are worth paying for
3. Salt formation or free-basing — usually cheap, sometimes not, depending on crystallization behavior
4. Isolation-only operations — a filtration or a solvent swap, cheap, but they still consume vessel time

A route described as “five steps” in a paper is frequently seven or eight steps when you count the protections and the salt break. Ask a supplier how many isolated intermediates their quote assumes. Two suppliers can be quoting the same molecule with different step counts and the comparison is meaningless until you align them.

Overall Yield and How It Compounds

Overall yield is step yield raised to the power of step count, and the arithmetic is harsher than most buyers expect.

Take a route where every step runs at 85 percent — a respectable, well-behaved number that most chemists would be pleased with on an individual reaction. Over eight steps:

Step	Yield at that step	Cumulative material remaining
1	85 percent	85.0 percent
2	85 percent	72.3 percent
3	85 percent	61.4 percent
4	85 percent	52.2 percent
5	85 percent	44.4 percent
6	85 percent	37.7 percent
7	85 percent	32.1 percent
8	85 percent	27.2 percent

Eight steps at 85 percent each delivers 27 percent overall. To ship 100 grams of final product you must commit roughly 370 grams of material equivalent at step one, plus every reagent, solvent and hour required to carry it forward — and then lose nearly three-quarters of it along the way.

The Sensitivity Nobody Expects

Now change one number. Drop the average to 75 percent per step and eight steps delivers 10 percent overall. Raise it to 90 percent and you get 43 percent. A ten-point swing in average step yield changes the amount of starting material you must commit by more than a factor of four.

This is the mathematical reason process development pays for itself at scale, and it is the same arithmetic behind the process mass intensity metrics tracked by the ACS Green Chemistry Institute Pharmaceutical Roundtable — poor overall yield and high solvent consumption are the same problem measured two ways. Spending three weeks improving two steps from 70 percent to 88 percent does not improve the route by 18 percent — it can nearly double the overall yield, and on a multi-kilo campaign that difference dwarfs the development cost. It is also why route optimization is priced separately from synthesis: it is a distinct piece of work with a distinct return. Our discussion of scale-up challenges in custom synthesis covers where those yield losses typically appear when a route moves out of the round-bottom flask.

Why Suppliers Quote With a Yield Assumption

A quote for a novel target contains an estimate of overall yield, and that estimate is the biggest single uncertainty in the number. Honest suppliers handle this in one of three ways: they quote a range, they quote a fee-for-service arrangement where you pay for the attempt rather than the outcome, or they quote fixed-price with a margin sized to absorb the risk. The third is the most expensive per delivered gram and the most comfortable for the buyer, which is exactly the tradeoff. Ask which model you are being quoted under. If nobody says, assume fixed-price with risk margin built in.

Starting Material: Commercial Shelf Versus Made-to-Order

Whether your route begins from something a supplier can buy or something they must first synthesize is a step-change in cost, not an incremental one.

A route starting from a commercially available building block starts on day one. A route starting from a compound that must itself be made adds a complete sub-project: its own steps, its own yield losses, its own analysis, and its own risk of failure — and that sub-project sits upstream of everything, so its failure kills the campaign.

The Practical Test

Before you finalize a route, check every proposed starting material against actual catalog availability at the quantity you need, not just at the milligram level. A compound listed at 100 mg is not the same as a compound available at 500 g. Availability at gram scale and availability at kilo scale are different markets with different suppliers and, frequently, different prices per gram by an order of magnitude.

Common well-supplied cores make good route entry points precisely because they are made in volume. Compounds like 4-Fluoroindole (CAS 387-43-9) and 3-Bromo-1H-indazole (CAS 40598-94-5) sit in the broadly-supplied part of the heterocyclic compounds catalog, which means a route that starts from them is starting from a known price and a known lead time. Contrast that with a heavily substituted variant of the same core that exists in one catalog at 250 mg — technically available, practically a synthesis project.

Protected Building Blocks Are Often the Cheaper Path

Buyers sometimes resist paying for a protected starting material when the unprotected version is cheaper per gram. That comparison usually misses the protection step you are about to run yourself: reagent, vessel time, workup, purification and analysis, at a yield below 100 percent. Buying 1-BOC-3-aminopiperidine (CAS 184637-48-7) rather than the free amine plus a Boc protection is frequently cheaper on delivered cost even when it looks more expensive per gram, and the broader Boc-protected compounds category exists for exactly this reason. Run the comparison on cost per gram of product delivered, not cost per gram of input purchased.

Reaction Conditions That Force Specialized Equipment

A quote rises sharply when any step in the route requires equipment that a standard synthesis lab does not have running by default, because that equipment is capacity-constrained and its time is priced accordingly.

Cryogenic Chemistry

Steps run at −78 °C — organolithium additions, directed metalations, low-temperature enolate chemistry — require jacketed reactors with cryogenic cooling, and both the cooling itself and the reactor time are expensive. Dry ice and acetone works fine at 5 grams. At 5 kilograms you need a cryogenic vessel, and the number of those in a facility is small. A route with one cryogenic step will be quoted higher than an otherwise identical route without one, and a route with two will be higher again, because the constraint is vessel availability across a scheduling window rather than a per-reaction consumable cost.

High-Pressure Hydrogenation

Catalytic hydrogenation above atmospheric pressure requires rated pressure vessels, hydrogen handling infrastructure, and a facility permitted to run them. There is also a catalyst cost that is genuinely material for precious metal systems, and a catalyst recovery question at scale. Hydrogenation is usually the cheap way to do a reduction when the facility is set up for it and an expensive detour when it is not — which is why “can you run hydrogenations, and to what pressure” is a useful early question rather than a late one.

Air- and Moisture-Sensitive Handling

Chemistry that dies on contact with air or water — many organometallics, most Grignard and organolithium work, a good deal of catalysis — requires inert atmosphere throughout: glovebox or Schlenk work at small scale, nitrogen-inerted reactors at large scale, and dried solvents on a still or from a solvent purification system. The cost is in the extra operations and the failure rate, not just the equipment. An accidental air exposure at step seven of an eight-step route is an expensive afternoon.

Hazardous Reagents

Some reagents carry a cost that has nothing to do with their catalog price. Azides, diazo compounds, strong oxidants, phosgene equivalents, hydrogen fluoride sources and pyrophorics require engineering controls, additional risk assessment, sometimes a dedicated bay, and always a slower operating pace. A facility that will run them prices that in. A facility that will not run them declines to quote — see the section below on refusals.

Purification: The Biggest Hidden Cost at Scale

Purification is the single most underestimated line in a custom synthesis quote, and at kilogram scale it can exceed the cost of the chemistry it follows.

The reason is that chromatography does not scale gracefully. In a research lab, a silica column is the default answer to any purification problem: it is fast, it is general, and the cost is a bag of silica and an afternoon. At kilo scale the same operation consumes tens of kilograms of silica, hundreds of liters of solvent, days of operator time, and generates a solvent waste stream that must be disposed of. A single kilo-scale chromatographic purification can cost more than the entire preceding synthetic sequence.

Crystallization Is the Scalable Answer

Crystallization scales almost linearly and is dramatically cheaper per kilogram. It is also harder to develop: it requires finding a solvent system in which the product crystallizes and the impurities do not, understanding the polymorph behavior, and confirming the process is reproducible across lots. That development is real work with a real cost — typically days to weeks of a chemist’s time — but it is a one-time cost that pays back on every subsequent campaign.

The practical implication for a buyer: at gram scale, chromatography is fine and crystallization development is not worth paying for. Somewhere between 100 grams and 1 kilogram the balance inverts. If you expect to reorder at scale, ask the supplier to develop a crystallization on the first campaign even though it costs more up front. If you never intend to reorder, do not pay for it.

Purity Specification Drives Purification Cost Non-Linearly

The relationship between requested purity and cost is a curve, not a line.

Purity target	Typical purification approach	Relative cost
90 to 95 percent	Single crystallization or short plug	Baseline
95 to 97 percent	Crystallization with optimized solvent system	1.1 to 1.3x
97 to 99 percent	Repeat crystallization or preparative chromatography	1.5 to 2.5x
Above 99.5 percent	Multiple recrystallizations, prep HPLC, or both	3x and up
Specified single impurity below 0.1 percent	Targeted removal, method development, additional analysis	Highly variable, often the largest single line

That last row is the one that catches people. A general purity number is a purification problem. A named impurity with a low individual limit is a method development problem plus a purification problem plus an analytical problem, and it is priced as all three. If the low limit is genuinely required — a genotoxic alert, a regulatory specification — say so up front. If it was copied from a template, delete it.

Analytical and Documentation Package

The analytical package is a separately costed deliverable, and the gap between the cheapest and most expensive version of it is wide enough to change the quote materially.

Three Tiers, Roughly

Research-grade certificate of analysis. Identity by NMR, purity by HPLC or GC with a chromatogram, appearance. Sufficient for a discovery chemist who will use the material in an assay and confirm it themselves. Adds relatively little to a quote.

Full characterization. Adds mass spectrometry, elemental analysis or quantitative NMR for assay, water content by Karl Fischer, residual solvents by GC headspace, residue on ignition, and chiral purity by chiral HPLC where relevant. Appropriate for material entering a formal study or being used as a reference. This tier is a meaningful line item and often needs its own method development if no method exists.

GMP documentation. A different category entirely, not an increment. Validated analytical methods, qualified equipment, executed batch records, deviation handling, QA release by a named quality unit, retained samples, and a fully documented chain from raw material to product. The ICH quality guidelines define what this package has to contain. GMP typically multiplies the total project cost rather than adding to it, and the multiple is driven mostly by documentation and quality-unit labor rather than by chemistry. Our comparison of GMP versus non-GMP chemical manufacturing covers where the line actually sits.

The correct question is not “what analysis can you provide” but “what does the material’s intended use require.” Ordering GMP material for a tool compound going into a cell assay is a common and expensive mistake. If you are unsure which tier applies, outsourcing analytical testing walks through the decision.

Method Development Is Often the Hidden Line

If your compound has no existing analytical method, someone has to develop one before any purity number can be reported at all. HPLC method development for a new molecule — finding conditions that separate the product from its process impurities and degradants — is typically several days of instrument and chemist time. It is real work and it appears in a quote whether or not it is broken out separately. Ask for it to be broken out. It is also reusable across every future lot, so it should be paid once, not once per campaign.

Scale and the Non-Linear Cost Curve

Ten grams does not cost ten times what one gram costs, and understanding the shape of the curve is worth real money.

A custom synthesis project has three cost components with different scaling behavior:

1. Fixed project costs — route scouting, literature work, method development, project management, documentation. Paid once regardless of quantity.
2. Semi-fixed costs — reactor setup, cleaning, analytical runs per step. These scale in steps as you move between equipment tiers, not smoothly.
3. Variable costs — starting materials, reagents, solvents, catalysts, waste disposal. These scale roughly linearly with mass.

At 1 gram, the fixed component dominates and you are essentially paying for a chemist’s project, not for material. At 100 grams the fixed cost is spread across a hundred times more product and per-gram price falls steeply. Somewhere in the kilogram range the variable costs take over and the per-gram price flattens — it will keep declining slowly as you buy raw materials in better volume tiers, but the dramatic part of the curve is behind you.

The Practical Consequence

Order the total quantity you need in one lot rather than in repeated small lots. Three separate 5 gram orders across a year will cost substantially more than one 15 gram order, because you pay the fixed component three times and you also pay three times for the analytical release. You additionally get three lots with three sets of impurity profiles, which is its own problem if the material feeds a comparative study.

The exception is material with a short retest date or unstable storage behavior. There, buying more than you can use before it degrades is not a saving. Our post on custom synthesis from milligram to multi-ton covers what actually changes as the scale bands move, and where each band’s equipment ceiling sits.

Timeline: What Rush Actually Costs

A rush timeline typically adds 25 to 60 percent, and the reason is not that chemists work faster when paid more.

What you are actually buying with a rush premium is four things:

• Queue displacement. Your project moves ahead of work already scheduled. The supplier absorbs the cost of that disruption and passes it on.
• Parallelization instead of optimization. Under normal timing, a chemist runs a small-scale trial, learns from it, and then commits material. Under rush, steps get committed at scale on the first attempt. That raises the failure rate and lowers the yield, both of which cost money.
• Premium starting materials. Expedited freight, spot purchases, or buying a more expensive but immediately available grade instead of the economical one on a four week lead time.
• Overtime and shift work. Real labor cost at a premium rate.

There is also a risk you are buying that is not in the quote: rush campaigns fail more often. A failed rush campaign costs the original money, the repeat campaign, and the schedule you were trying to protect in the first place. If the deadline is genuine, pay the premium. If the deadline came from a calendar rather than an experiment, the cheapest thing you can do is move it.

What a Normal Timeline Looks Like

For a non-GMP custom synthesis of a novel target at gram scale with a literature-precedented route, 8 to 14 weeks is typical: one to two weeks for route review and material ordering, four to eight weeks of synthesis, and two to three weeks of purification, analysis and release. Novel routes with no precedent, chiral targets, or anything above the kilogram mark run longer, and any facility will give you a range rather than a date. Treat a supplier who quotes a hard date on a novel route with no conditions attached the same way you would treat a quote with no questions attached.

Chirality: Why Enantiopure Costs More Than Twice as Much

A single enantiomer costs more than the racemate, and if the route uses classical resolution the premium is structurally worse than 2x.

The arithmetic is blunt. Classical resolution throws away half the material by design. You make the racemate, form diastereomeric salts with a resolving agent, crystallize the one you want, and discard or recycle the other. Best case you recover a little under 50 percent of the racemate as the desired enantiomer, and you have paid for 100 percent of it — plus the resolving agent, plus the extra crystallizations, plus the chiral analysis to prove the enantiomeric excess.

The alternatives each carry their own cost profile:

Approach	Material efficiency	Cost profile	When it makes sense
Classical resolution	Up to 50 percent, less in practice	Cheap to develop, expensive per gram	Small quantities, no time for development
Chiral pool starting material	High	Cost sits in the starting material	An enantiopure building block exists commercially
Asymmetric catalysis	High	Expensive to develop, cheap at scale	Large or repeat campaigns justify development
Enzymatic resolution with racemization	Can approach 100 percent	Development-heavy	Multi-kilo, repeat production
Chiral preparative HPLC	Up to 50 percent, plus recycle	Very expensive per gram at scale	Milligrams to low grams, or urgent

The chiral-pool route is the one buyers most often overlook. Starting from a commercially available enantiopure building block — (S)-2-Methylpyrrolidine (CAS 59335-84-1) or (R)-3-Methylmorpholine (CAS 74572-04-6), for instance — moves the entire chirality problem into a purchased material where it has already been solved at production scale. When it is available for your target, it is almost always the cheapest answer. The piperidines and piperazines category is a good place to look for saturated nitrogen heterocycle building blocks in both racemic and single-enantiomer forms.

Also specify how enantiomeric excess will be measured. Two suppliers can both report 99 percent ee against different chiral HPLC methods and mean different things. Agree the method, not just the number.

What You Can Change to Lower Your Quote

Most of the drivers above are set by your molecule. These are set by your request, and every one of them is negotiable.

Lever	What to change	Typical effect	When not to do it
Relax purity	Specify the purity your assay or process actually requires instead of a default 99 percent	Can be the largest single saving, especially at scale	Regulated material, reference standards, anything with a filed specification
Widen the delivery window	Give a range instead of a date, or add four weeks	Removes rush premium; often 20 to 40 percent	A genuine clinical or study deadline
Accept a different salt or solid form	Let the supplier propose the salt that crystallizes well	Can convert an expensive chromatography into a cheap crystallization	Solid-state form is part of your specification or IP
Order one larger lot	Consolidate a year of demand into a single campaign	Avoids paying fixed project costs and release testing two or three times	Short retest date, unstable material, uncertain program future
Supply your own starting material	Ship material you already hold, with its certificate of analysis	Removes both the purchase cost and its lead time	You cannot guarantee quantity or quality on the supplier’s schedule
Share your route	Send the route you want rather than asking for a blind route design	Removes a scouting phase that can be a significant fraction of a novel-target quote	You genuinely want route options and a better route is worth paying for
Drop unneeded analysis	Match the analytical package to the material’s actual use	Meaningful on small orders where analysis is a large fraction of total	Anything going into a study, a filing, or a comparative dataset
Allow a solvent or reagent substitution	Let the supplier swap an expensive or restricted reagent for an equivalent	Occasionally large, especially with precious metal catalysts	The specific reagent affects impurity profile you care about
Skip crystallization development	Accept chromatographed material for a one-off order	Saves development time on material you will never reorder	You will reorder at scale, in which case pay for it now

Two of these deserve a warning. Supplying your own starting material shifts risk to you: if the material fails on receipt or runs short mid-campaign, the schedule is your problem. Agree in writing what happens in both cases. And sharing your route removes the supplier’s opportunity to find a cheaper one — if your route came from a paper rather than from process development, it may be worth paying for the alternative.

For a broader view of where outsourced synthesis sits against building the capability internally, see our contract R&D versus in-house labs cost analysis.

Why a Supplier Declines to Quote

A refusal to quote is not a rejection of your business. It is usually the most useful signal you will get from a supplier, and it is worth understanding what triggers one.

The Legitimate Reasons

Facility capability. The route requires a hazard class, a pressure rating, a temperature range or a containment level the facility does not have. A supplier who runs the chemistry anyway on borrowed judgment is a worse partner than one who declines.

Regulatory and controlled substances. Scheduled substances, precursors on control lists, and material subject to export restriction require licensing that many facilities do not hold. Suppliers also decline compounds with obvious structural alerts, and structures that fall in the vicinity of controlled analogs. The DEA list of controlled substances and the EPA TSCA inventory are where those constraints are documented.

Infeasible request. A kilogram of a twelve-step target in six weeks is not a hard request; it is an impossible one. Quoting it would be dishonest. Similarly, a request too vague to cost — no quantity, no purity, no timeline, structure only — cannot be quoted, only guessed at.

No credible precedent. If a step has no precedent in the literature and no analogous transformation the chemist can reason from, the supplier is being asked to run a research project priced as a delivery. Some suppliers will take that on as a fee-for-service feasibility study, which is the honest structure for it. Quoting it as fixed-price delivery is not.

Commercial mismatch. A facility set up for multi-kilo campaigns will often decline a 500 milligram order, not because it is difficult, but because the fixed costs make the quote unattractive to both sides. Our US-based custom synthesis capability map covers which facilities cluster at which scale bands.

The Quote With No Questions Is the Warning Sign

Here is the counterintuitive part: the quote that arrives fastest, with no questions attached, is the one to worry about.

Costing a novel synthesis requires knowing things that are not in a structure drawing. What purity, measured how? What salt or free form? What analytical package? What quantity, and is it a one-off or the first of several? What is the material for, and does it need to be free of a specific impurity class? Is there a route you want followed, or is route selection part of the job? What is the real deadline?

A supplier who quotes without asking any of these has either done this exact molecule before — in which case they should say so — or they have priced a guess. A priced guess resolves in one of two directions. Either the quote is padded with enough margin to cover every assumption, in which case you are overpaying, or it is not, in which case you will receive a change order partway through the campaign or material that does not meet a specification nobody ever agreed.

Ask any supplier who quotes quickly: what did you assume? The quality of that answer tells you more than the number does. A good supplier can list their assumptions in four bullet points and tell you which one, if wrong, moves the price most. For a fuller comparison of how different supplier types handle this stage, see our honest comparison of ChemContract and large CDMOs.

Reading a Quote Once You Have Three of Them

When quotes for the same target vary widely, the variance is almost always explained by a difference in assumption rather than a difference in efficiency. Before comparing numbers, align these:

1. Step count and isolated intermediates — are they quoting the same route?
2. Purity specification and the method used to measure it — 98 percent by HPLC at 254 nm is not 98 percent by qNMR
3. Quantity basis — is that free base or salt, and is the mass corrected for water and residual solvent?
4. Analytical deliverables — which tier, and is method development included or extra?
5. Yield risk — fixed price, fee-for-service, or ranged?
6. What happens if the route fails — who pays for the second attempt?
7. Timeline commitment — a target or a contractual date?

Point six is the one that most often distinguishes a genuinely cheap quote from an apparently cheap one. If a route fails at step six of eight, the arrangement you agreed before starting determines whether the second attempt is a conversation or a dispute.

ChemContract Research has run US-based custom synthesis from milligram to multi-ton since 2000, with cryogenic capability to −78 °C, high-pressure hydrogenation, flow chemistry, fluorination, and chiral synthesis and resolution in house. Contract R&D covers route scouting and process optimization where the yield arithmetic above says it will pay for itself, and analytical services covers method development and the full characterization package. Send us the structure, the quantity, the purity you actually need and the date that actually matters, and we will return a quote within 24 hours with the assumptions listed.

Frequently Asked Questions

What drives the cost of a custom synthesis quote the most?

Step count and overall yield, because they compound. Every additional step multiplies the material you must charge at the start and adds a full cycle of reaction, workup, purification and analysis. A nine step route at 85 percent per step delivers about 27 percent overall, so you buy roughly four kilograms of committed material for every kilogram delivered.

Why is 10 grams not ten times the price of 1 gram?

Because a large part of the cost is fixed per project rather than per gram. Route scouting, method development, analytical setup and documentation are paid once whether you order 1 gram or 10. Above that, per-gram price falls steeply, then plateaus once raw materials and vessel time dominate and fixed costs are fully spread.

Does asking for higher purity always cost more?

Above about 97 percent, yes, and the curve steepens sharply. Moving from 95 to 98 percent is often one extra recrystallization. Moving from 98 to 99.5 percent may require chromatography, which at kilo scale can cost more than the entire synthesis preceding it. Specify the purity your application actually needs.

How much does a rush timeline add to a custom synthesis quote?

A genuine rush typically adds 25 to 60 percent, and sometimes more. You are paying to displace other work in the queue, to run steps in parallel with less optimization, to accept a lower yield from a route that was not refined, and often for expedited or premium-priced starting materials. Rush also raises the chance of a repeat campaign.

Why would a supplier refuse to quote my synthesis?

Common reasons are a hazard the facility is not equipped to contain, a reagent under regulatory control, a target with structural alerts, an unrealistic combination of scale and timeline, a request too vague to cost, or a route with a step that has no credible precedent. A refusal to quote is usually a supplier protecting you from a failed campaign.

Should I supply my own starting material?

If you already hold it at the required quality and quantity, yes, it usually reduces the quote and shortens the timeline. Send the certificate of analysis first so the supplier can confirm it is fit for purpose, and agree in writing what happens if the material fails on receipt or the campaign consumes more than expected.